IGLL5 controlled by super-enhancer affects cell survival and MYC expression in mature B-cell lymphoma
© 2024 The Author(s)..
IGLL5 is shown to be located near super-enhancer (SE) in B-cell tumors, and this gene is frequently mutated and a target of translocation in B-cell tumors. These results suggest roles of the IGLL5 in tumorigenesis; however, its functional properties have been unclear. We found that two mature B-cell lymphoma cell lines expressed IGLL5 mRNA with Cλ1 segment. JQ1 treatment resulted in down-expression of IGLL5, indicating that IGLL5 is controlled by SE. IGLL5 knockdown induced cell death with down-expression of MYC. Our results suggested that IGLL5 might have a role in survival of mature B-cell tumors and involvement in MYC expression. (100 words).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Leukemia research reports - 21(2024) vom: 15., Seite 100451 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hosoi, Hiroki [VerfasserIn] |
---|
Links: |
---|
Themen: |
Immunoglobulin lambda like polypeptide 5 (igll5) |
---|
Anmerkungen: |
Date Revised 07.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.lrr.2024.100451 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369343484 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369343484 | ||
003 | DE-627 | ||
005 | 20240307232703.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240306s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.lrr.2024.100451 |2 doi | |
028 | 5 | 2 | |a pubmed24n1319.xml |
035 | |a (DE-627)NLM369343484 | ||
035 | |a (NLM)38444524 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hosoi, Hiroki |e verfasserin |4 aut | |
245 | 1 | 0 | |a IGLL5 controlled by super-enhancer affects cell survival and MYC expression in mature B-cell lymphoma |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 07.03.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2024 The Author(s). | ||
520 | |a IGLL5 is shown to be located near super-enhancer (SE) in B-cell tumors, and this gene is frequently mutated and a target of translocation in B-cell tumors. These results suggest roles of the IGLL5 in tumorigenesis; however, its functional properties have been unclear. We found that two mature B-cell lymphoma cell lines expressed IGLL5 mRNA with Cλ1 segment. JQ1 treatment resulted in down-expression of IGLL5, indicating that IGLL5 is controlled by SE. IGLL5 knockdown induced cell death with down-expression of MYC. Our results suggested that IGLL5 might have a role in survival of mature B-cell tumors and involvement in MYC expression. (100 words) | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Immunoglobulin lambda like polypeptide 5 (igll5) | |
650 | 4 | |a Mature b-cell lymphoma | |
650 | 4 | |a Super-enhancer, SiRNA | |
700 | 1 | |a Tabata, Shotaro |e verfasserin |4 aut | |
700 | 1 | |a Kosako, Hideki |e verfasserin |4 aut | |
700 | 1 | |a Hori, Yoshikazu |e verfasserin |4 aut | |
700 | 1 | |a Okamura, Tadashi |e verfasserin |4 aut | |
700 | 1 | |a Yamashita, Yusuke |e verfasserin |4 aut | |
700 | 1 | |a Fujimoto, Kota |e verfasserin |4 aut | |
700 | 1 | |a Kajioka, Daiki |e verfasserin |4 aut | |
700 | 1 | |a Suzuki, Kentaro |e verfasserin |4 aut | |
700 | 1 | |a Osato, Motomi |e verfasserin |4 aut | |
700 | 1 | |a Yamada, Gen |e verfasserin |4 aut | |
700 | 1 | |a Sonoki, Takashi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Leukemia research reports |d 2012 |g 21(2024) vom: 15., Seite 100451 |w (DE-627)NLM229883648 |x 2213-0489 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2024 |g day:15 |g pages:100451 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.lrr.2024.100451 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2024 |b 15 |h 100451 |